Garodia Chemicals Reports ₹3.92 Crore Profit on Loan Settlement, Zero Revenue

Garodia Chemicals Ltd has reported a net profit of ₹3.92 crore for the financial year ended March 31, 2026. This profit was achieved despite recording zero revenue from operations. The primary driver for the profit was other income of ₹4.06 crore, which management clarified relates to the settlement of loans from promoters and related entities as part of an NCLT-approved Base Resolution Plan (BRP).

The company also reported a significant reduction in total expenses to ₹0.14 crore from ₹0.21 crore in the previous year. This marks a shift from a net loss of ₹0.21 crore in FY25 to a profit in FY26.

Reader Takeaway: Profit from debt settlement offsets zero operational revenue; restructuring provides a clean slate.

What just happened

Garodia Chemicals announced its audited financial results for the fiscal year 2025-26. Key highlights include a net profit of ₹3.92 crore, with revenue from operations at ₹0 crore. The profit was primarily derived from loan settlements under a Base Resolution Plan approved by the National Company Law Tribunal (NCLT). The company also completed a corporate restructuring involving capital reduction and the issuance of new equity to a new promoter.

Why this matters

This development signifies a major financial overhaul for Garodia Chemicals. The reported profit is non-operational, stemming from accounting gains related to debt resolution rather than core business activities. The restructuring, including capital reduction and the entry of a new promoter, aims to clean up the company's balance sheet. Investors will be closely watching the company's ability to generate operational revenue and sustain business activities post-restructuring.

The backstory

The company has undergone significant financial distress, leading to the NCLT process. The Base Resolution Plan approved by the NCLT was crucial for its revival. This plan involved substantial changes to the company's capital structure.

What changes now

The corporate restructuring included a reduction of equity shares and face value, with the resulting capital reduction balance used to offset accumulated losses. Subsequently, 50,00,000 new equity shares of ₹1 each were allotted to a new promoter. The paid-up equity share capital has been revised to ₹0.53 crore. Borrowings have also been reduced to ₹0.32 crore as of March 31, 2026.

Risks to watch

The primary risk is the company's reliance on non-operational income for its reported profitability. Generating sustainable revenue from its core business activities will be critical for long-term viability. The success of the new promoter's strategy in reviving operations remains a key factor.

Peer comparison

Garodia Chemicals operates in the chemicals sector. However, comparing its current financial performance directly with peers is challenging due to its zero operational revenue and reliance on NCLT-driven financial restructuring for its profit.

Context metrics (time-bound)

• FY26 Net Profit: ₹3.92 crore (₹391.67 lakh)
• FY26 Revenue from Operations: ₹0 crore
• FY25 Net Profit/(Loss): ₹-0.21 crore (₹-20.77 lakh)
• FY26 Other Income: ₹4.06 crore (₹405.88 lakh)
• Capital Reduction: From 72,00,200 shares (₹10 face value) to 2,63,157 shares (₹1 face value).
• New Equity Allotment: 50,00,000 shares (₹1 face value) to new promoter.
• As of March 31, 2026, Borrowings: ₹0.32 crore (₹31.74 lakh).

What to track next

Investors should monitor the company's efforts to generate operational revenue, any future business strategies announced by the new promoter, and updates on the NCLT process and its implications.